Cedars-Sinai stem cell researchers have been awarded a $3M grant Read more…
The gene therapy is currently in Phase I/II trials as a treatment for beta thalassemia and sickle cell anemia. Read more…
SGMO’s experimental gene/cell therapy was used safely in 6 patients infected with HIV in the first trial Read more…
Startup, Constellation Pharmaceuticals aims to develop drugs that target a broad array of diseases by manipulating one of the fundamental mechanisms by which cells control the expression of genes: epigenetics. Read more…
Although congenital heart disease represents the most common major birth defect, scientists have not previously identified the common variation in the genes that give rise to it. Now genetics and cardiology researchers have discovered a genetic variant on chromosome 5 that strongly raises the risk of congenital heart disease. Read more…
A gene therapy technique restored some muscle function for months in patients with a certain type of muscular dystrophy. This is the first time such a feat has been performed in humans, with findings published at the annual meeting of the American Society of Gene & Cell Therapy. If replicated, the findings could provide hope for people with this and other forms of muscular dystrophy. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.